Literature DB >> 7802034

Partial X chromosome trisomy with functional disomy of Xp due to failure of X inactivation.

K M Gustashaw1, V Zurcher, L H Dickerman, R Stallard, H F Willard.   

Abstract

A 5-month-old girl with mild phenotypic abnormalities, developmental delay, and seizures was found to have the de novo karyotype 46,XX,-13,+der(13)t(X;13)(p21.2;p11.1). The partial trisomy of Xp21.2-->pter was confirmed with fluorescence in situ hybridization, using an X chromosome painting probe and several cosmid and YAC probes for Xp sequences. Replication banding showed that one of the structurally normal X chromosomes was late-replicating, but that the Xp segment of the der(13) was early-replicating in all cells examined. Since segments of the X chromosome separated from the X inactivation center in Xq13.2 cannot undergo X inactivation, the result is functional disomy of distal Xp. As the loss of short arm material from chromosome 13 is not considered to be clinically significant, the genomic imbalance of Xp expressed in this patient most likely accounts for her abnormal phenotype.

Entities:  

Mesh:

Year:  1994        PMID: 7802034     DOI: 10.1002/ajmg.1320530109

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  3 in total

1.  Clinical Outcomes and Counselling Issues regarding Partial Trisomy of Terminal Xp in a Child with Developmental Delay.

Authors:  Karen L Sheath; Roberto L Mazzaschi; Salim Aftimos; Nerine E Gregersen; Alice M George; Donald R Love
Journal:  Sultan Qaboos Univ Med J       Date:  2013-05-09

2.  Functional Xp disomy and de novo t(X;13)(q10;q10) in a girl with hypomelanosis of Ito.

Authors:  L S Correa-Cerro; H Rivera; A I Vasquez
Journal:  J Med Genet       Date:  1997-02       Impact factor: 6.318

3.  Development of rainbow trout hepatoma cell lines: effect of pro-IGF-I Ea4-peptide on morphological changes and anchorage-independent growth.

Authors:  Maria J Chen; P Peter Chiou; Bih-Ying Yang; Hung Chieh Lo; Jin-Ki Son; Jerry Hendricks; George Bailey; Thomas T Chen
Journal:  In Vitro Cell Dev Biol Anim       Date:  2004 Mar-Apr       Impact factor: 2.416

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.